Form 4: Sight Sciences CTO Sells Shares to Cover Tax Liability

Sight Sciences, Inc.'s Chief Technology Officer, David Badawi, sold 5,679 shares of common stock for $4.174 per share to cover tax obligations related to restricted stock unit vesting.

Summary

• David Badawi, Chief Technology Officer and Director of Sight Sciences, Inc. (SGHT), reported a transaction on July 3, 2025.
• The transaction involved the disposition of 5,679 shares of Sight Sciences common stock.
• The shares were sold at a price of $4.174 per share.
• The purpose of the sale was to cover the reporting person's tax liability associated with the vesting of restricted stock units.
• Following this transaction, David Badawi directly beneficially owns 1,831,025 shares of Sight Sciences common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-planned sale.

Sentiment

Score: 5

Explanation: The transaction is a routine sale to cover tax obligations from RSU vesting, which is a neutral event and does not indicate a change in management's confidence or company performance. The small number of shares sold relative to total holdings further supports a neutral sentiment.

Industry Context

This filing is a routine insider transaction report, common for executives who receive equity compensation. It does not provide broader industry context or strategic updates for Sight Sciences, which operates in the medical device sector, specifically ophthalmology.

Stakeholder Impact

• Shareholders: The sale is a routine tax-related transaction and is unlikely to have a significant impact on shareholder sentiment or the company's stock price, given its pre-planned nature and relatively small size compared to the executive's total holdings.

Key Dates

Keywords

Sight Sciences, SGHT, David Badawi, Chief Technology Officer, Director, Insider Trading, Form 4, Stock Sale, Tax Liability, Restricted Stock Units, 10b5-1 Plan